Introduction {#s1}
============

Forces generated at dynamic plus-ends of microtubules drive directional movement of chromosomes and the mitotic spindle to achieve successful cell division ([@bib21]). During animal mitosis, dynamic plus-ends of microtubules emanating from the spindle interact with two macro-molecular complexes; kinetochores and the cortical force-generating machinery. Kinetochores consist of more than 100 different proteins assembled on centromeric DNA and surround dynamic microtubule plus-ends using multiple fibril-like microtubule-binding proteins and/or ring-like couplers to harness the energy of microtubule depolymerization for chromosome segregation ([@bib4]; [@bib7]; [@bib36]). In contrast, the cortical force-generating machinery assembles on the plasma membrane and pulls on the dynamic plus-ends of astral microtubules to define spindle position and orientation ([@bib11]; [@bib15]; [@bib16]). Spindle positioning determines daughter cell fate by controlling the distribution of polarized cell fate determinants and daughter cell size during both symmetric and asymmetric cell division ([@bib6]; [@bib25]; [@bib39]; [@bib55]). In metaphase human cells, the cortical machinery consists of evolutionary conserved protein complexes, including the cytoplasmic dynein motor, its binding partner dynactin, and the cortically-anchored NuMA-LGN-Gαi complex ([Figure 1A](#fig1){ref-type="fig"}) ([@bib23]). Prior work has conceptualized that the cortical complex is distributed along the cell cortex and individually pulls on astral microtubules using dynein-based motility and/or by controlling microtubule dynamics ([@bib23]; [@bib28]; [@bib31]). However, compared to the focal kinetochore structure, how this diffusion-prone membrane-associated complex efficiently captures and pulls on dynamic plus-ends of astral microtubules remains poorly understood. Here, we sought to understand the mechanisms of cortical pulling-force generation by reconstituting a minimal functional unit of the cortical force-generating complex in human cells using a light-induced membrane tethering. We found that cortical targeting of NuMA is sufficient to control spindle position, and that NuMA makes multiple, distinct contributions for spindle pulling through its N-terminal dynein recruitment domain, central long coiled-coil, and C-terminal microtubule-binding domains. In addition, we demonstrate that NuMA assembles focal clusters at the mitotic cell cortex that coordinate multiple dynein-based forces with NuMA's microtubule binding activities. We propose that the cortical Dynein-Dynactin-NuMA clusters (hereafter referred to as the cortical DDN clusters) act as the core spindle-pulling machinery that efficiently captures astral microtubules and generates cooperative pulling forces to position the mitotic spindle.

![Optogenetic targeting of NuMA to the mitotic cell cortex is sufficient for dynein-dynactin recruitment and spindle pulling.\
(**A**) Diagram summarizing cortical complexes in the indicated conditions. (**B**) Live fluorescent images of NuMA-RFP-Nano (upper) and DHC-SNAP (lower) in control metaphase cells (left), and LGN-depleted cells arrested with MG132. (**C**) Quantification of cortical NuMA-RFP-Nano and DHC-SNAP signals around the light illuminated region (n = 5). Error bars indicate SEM. (**D**) Quantification of the pole-to-cortex distance (NuMA-RFP-Nano, n = 10; RFP-Nano, n = 6). Error bars indicate SEM. (**E**) Kymographs obtained from image sequences in [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}. Asterisk indicates the duration in which one of the spindle poles moves away from the focal plane. (**F**) When NuMA-RFP-Nano (upper) was optogenetically repositioned at multiple adjacent cortical regions around the cell membrane by sequential illumination (from 1 to 9), the spindle (lower) rotated about 90° in a directed manner coupled with the changes in cortical NuMA enrichment in 55% (n = 11) of cells, but not by repositioning RFP-Nano alone ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}, n = 6). Dashed lines indicate the spindle axis. Scale bars = 10 μm.](elife-36559-fig1){#fig1}

Results {#s2}
=======

Optogenetic targeting of NuMA to the mitotic cell cortex is sufficient for dynein-dynactin recruitment and spindle pulling {#s2-1}
--------------------------------------------------------------------------------------------------------------------------

To understand the molecular mechanisms that underlie cortical force generation, we sought to reconstitute a minimal functional unit of the cortical force-generating machinery in human cells using a light-induced hetero-dimerization system (iLID) ([@bib17]). In this system, cytoplasmic RFP-Nano fusion proteins can be targeted to a locally illuminated region of the mitotic cell cortex by interacting with membrane-bound iLID ([Figure 1A](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1A--B](#fig1s1){ref-type="fig"}; and [Video 1](#video1){ref-type="video"}). Because the N-terminal fragment of NuMA is sufficient to recruit dynein-dynactin to the cell cortex ([@bib26]), we first sought to manipulate endogenous NuMA. We established triple knock-in cell lines that stably express membrane-targeted BFP-iLID (Mem-BFP-iLID), a NuMA-RFP-Nano fusion ([Figure 1A](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1C--E](#fig1s1){ref-type="fig"}), and SNAP-tagged dynein heavy chain (DHC) or the dynactin subunit p150 ([Figure 1---figure supplement 1F--G](#fig1s1){ref-type="fig"}). To prevent cortical recruitment of NuMA by the endogenous LGN-Gαi complex, we depleted LGN by RNAi ([Figure 1A](#fig1){ref-type="fig"} middle, 1B t = 0:00; [Figure 1---figure supplement 1H](#fig1s1){ref-type="fig"}). We then continuously illuminated the cortical region next to one of spindle poles (indicated by red circles in Figures) with a 488 nm laser to induce NuMA-RFP-Nano targeting. Light illumination induced the asymmetric cortical accumulation of NuMA-RFP-Nano within a few minutes ([Figure 1B--C](#fig1){ref-type="fig"}), which subsequently recruited DHC-SNAP and p150-SNAP ([Figure 1B--C](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2A--C](#fig1s2){ref-type="fig"}). The level of light-induced cortical NuMA is about three times higher than that of endogenous NuMA in metaphase, but similar to that in anaphase ([Figure 1---figure supplement 1I--J](#fig1s1){ref-type="fig"}).

###### Light-induced cortical targeting of RFP-Nano.

The dynamic cortical targeting and repositioning of RFP-Nano, in response to illuminations, are shown in this movie; it is played at five fps.

10.7554/eLife.36559.006

Importantly, following asymmetric NuMA-RFP-Nano targeting, the mitotic spindle was gradually displaced toward the light-illuminated region in 82.4% of cells (n = 17, [Figure 1B,D--E](#fig1){ref-type="fig"}, and [Video 2](#video2){ref-type="video"}), whereas spindle displacement and cortical dynein recruitment was never observed by targeting RFP-Nano alone (n = 6, [Figure 1D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}). Additionally, we found that light-induced repositioning of cortical NuMA is sufficient to drive spindle rotational re-orientation ([Figure 1F](#fig1){ref-type="fig"} and [Video 3](#video3){ref-type="video"}), and that light-induced NuMA targeting also causes spindle displacement in 71.4% of Gαi (1 + 2 + 3) depleted cells (n = 7, [Figure 1---figure supplement 2E--F](#fig1s2){ref-type="fig"}). These results indicate that light-induced cortical recruitment of the Dynein-Dynactin-NuMA (DDN) complex is sufficient, and that LGN/Gαi are dispensable for generating cortical spindle-pulling forces in human cells.

###### Light-induced cortical targeting of NuMA-RFP-Nano and spindle pulling.

Light-induced cortical recruitment of NuMA-RFP-Nano (left), and DHC-SNAP (right), and spindle displacement toward NuMA/DHC-enriched cell cortex have been shown in this movie; it is played at five fps.

10.7554/eLife.36559.007

###### Light-induced cortical repositioning of NuMA-RFP-Nano and spindle rotation.

Light-induced cortical repositioning of NuMA-RFP-Nano (left), and dynamics of SiR-tubulin (right) have been shown in this movie. The spindle rotation was coupled with cortical repositioning of NuMA. This movie is played at five fps.

10.7554/eLife.36559.008

Light-induced cortical DDN complex can pull on taxol-stabilized astral microtubules {#s2-2}
-----------------------------------------------------------------------------------

Cortical pulling forces are supposed to be generated by dynein-based motility on astral microtubules and/or astral microtubule depolymerization coupled with cortical anchorage ([@bib16]). To understand the contributions of astral microtubules to the spindle movement caused by light-induced cortical NuMA, we disrupted or stabilized astral microtubules using the microtubule-targeting drugs, nocodazole or taxol, respectively. In control cells, the metaphase spindle contains visible astral microtubules ([Figure 2A](#fig2){ref-type="fig"}, left) and is displaced following light-induced NuMA-RFP-Nano targeting ([Figure 2B,D--E](#fig2){ref-type="fig"}). In contrast, when astral microtubules were selectively disrupted by treatment with 30 nM nocodazole ([Figure 2A](#fig2){ref-type="fig"}, middle), the spindle was no longer displaced in 56% of cells (n = 5/9 cells), and only partially displaced in the remaining 44% of cells (n = 4/9) ([Figure 2C--E](#fig2){ref-type="fig"}), despite presence of cortical dynein ([Figure 2C](#fig2){ref-type="fig"} t = 5:30). This suggests that astral microtubules are required for spindle pulling by the light-induced cortical DDN complex.

![Light-induced cortical NuMA-dynein complex pulls on taxol-stabilized astral microtubules.\
(**A**) Fluorescent images of astral microtubules in fixed HCT116 cells treated with drugs as indicated. Cells were arrested at metaphase with MG132 for 1 hr, and DMSO/nocodazole or taxol were then added for 30 or 1 min, respectively. Images are maximally projected from 15 z-sections acquired using 0.2 μm spacing. (**B** and **C**) Live fluorescent images of NuMA-RFP-Nano (upper) and DHC-SNAP (lower) treated with DMSO (**B**) or nocodazole (**C**). (**D**) Kymographs obtained from image sequences in (**B**) and (**C**) showing the movement of the spindle at 30 s intervals. (**E**) Pole-to-cortex distance for control (black, n = 5), and nocodazole-treated cells (blue or light-blue). Blue and light-blue graphs indicate immobile (n = 5/9) and partially mobile pools (n = 4/9), respectively. Error bars indicate SEM. (**F** and **G**) Live fluorescent images of NuMA-RFP-Nano (upper), and SiR-tubulin and SiR-DNA ([@bib32]) (lower), treated with DMSO (**F**) or taxol (**G**). DMSO and Taxol were added at −1:00, and light illumination began at 0:00, when SiR-tubulin images were selectively abolished by taxol treatment. (**H**) Kymographs obtained from image sequences in (**F**) and (**G**) at 30 s intervals. In taxol-treated cells, the spindle did not attach to the cell cortex as indicated with an asterisk, likely due to stabilized astral microtubules. (**I**) Pole-to-cortex distance for control (black, n = 4), and taxol-treated cells (red, n = 5). Error bars indicate SEM. Scale bars = 10 μm.](elife-36559-fig2){#fig2}

Treatment with 10 μM taxol stabilized astral microtubules based on increases in both the length and number of astral microtubules 1 min after addition of taxol ([Figure 2A](#fig2){ref-type="fig"}, right) ([@bib43]). Importantly, even in the presence of 10 μM taxol, the spindle was gradually displaced toward the light-illuminated region ([Figure 2H-G](#fig2){ref-type="fig"}, t = 5:00). In these taxol-treated cells, the velocity of spindle movement was slower than that observed in control cells ([Figure 2F--I](#fig2){ref-type="fig"}), suggesting that depolymerization of astral microtubules may also contribute to force generation, although this reduced velocity might be caused alternatively by cortical pushing by stabilized astral microtubules. In these experiments, we visualized spindle microtubules with 50 nM SiR-tubulin ([@bib33]), a fluorescent docetaxel derivative, and confirmed the presence of 10 μM taxol by the decrease of SiR-tubulin intensity ([Figure 2G](#fig2){ref-type="fig"} t = 0:00), likely due to competition for the same microtubule-binding site. These results suggest that the light-induced cortical DDN complex generates cortical pulling forces by using dynein-based motility on astral microtubules even if microtubule depolymerization is inhibited.

Dynein activity is required for spindle displacement by the cortical DDN complex {#s2-3}
--------------------------------------------------------------------------------

Recently, ciliobrevin D was developed as a specific dynein inhibitor ([@bib10]). This compound inhibits dynein's microtubule gliding and ATPase activity, but not the association between ADP-bound dynein and microtubules in vitro. To understand the requirement of these dynein activities for force generation, we next sought to analyze spindle displacement following ciliobrevin D treatment. In HCT116 cells, we found that ciliobrevin D treatment in interphase caused mitotic phenotypes including chromosome misalignment similar to dynein degradation ([@bib40]) under 0.5%, but not 10%, FBS culture conditions ([Figure 3---figure supplement 1A--D](#fig3s1){ref-type="fig"}), consistent with a previous report ([@bib10]). We next added ciliobrevin D in metaphase-arrested cells. Although dynein activity is required to maintain spindle bipolarity, we found that spindle bipolarity was maintained for \~30 min following the treatment of ciliobrevin D, and was gradually disrupted during the subsequent 30--60 min ([Figure 3---figure supplement 1E--G](#fig3s1){ref-type="fig"}). We next performed the optogenetic spindle-pulling assay during the initial 60 min of ciliobrevin treatment according to the Procedure depicted in [Figure 3A](#fig3){ref-type="fig"}. In control cells, light-induced targeting of NuMA displaced the spindle in 80% of cell (n = 10, [Figure 3B and D](#fig3){ref-type="fig"}). In contrast, the spindle was not displaced in 75% of ciliobrevin D-treated cells (n = 12, [Figure 3C--D](#fig3){ref-type="fig"}), whereas dynein was normally recruited to the cell cortex and the bipolar spindle structure was maintained during the assay. These results suggest that light-induced NuMA not only recruits, but also activates dynein at the cell cortex to generate cortical pulling forces.

![Dynein activity is required for spindle pulling, but light-induced cortical dynein targeting is not sufficient to pull on the spindle.\
(**A**) Schematic of experimental procedures. The FBS concentration in the culture medium was changed from 10 to 0.5% at the 68 hr mark. DMSO or ciliobrevin D was added at the 69.5 hr mark and the cells were analyzed for 1 hr. (**B** and **C**) Live fluorescent images of NuMA-RFP-Nano (upper) and DHC-SNAP (lower) treated with DMSO (**B**) or ciliobrevin D (**C**). (**D**) Kymographs obtained from image sequences in (**B**) and (**C**) showing the movement of the spindle at 30 s intervals. (**E**) Cortical complexes formed by light-induced targeting of Nano-mCherry-DHC. (**F**) Left: live fluorescent images of Nano-mCherry-DHC (upper) and p150-SNAP (lower). Right: kymograph obtained from image sequences on the left. (**G**) Quantification of cortical Nano-mCherry-DHC and p150-SNAP signals around the light illuminated region (n = 6). Error bars indicate SEM. (**H**) Live fluorescent images of Nano-mCherry-DHC (upper) and NuMA-SNAP (lower). (**I**) Measurement of the pole-to-cortex distance (n = 10). Error bars indicate SEM. Scale bars = 10 μm.](elife-36559-fig3){#fig3}

Light-induced cortical targeting of dynein is not sufficient to pull on the spindle in human cells {#s2-4}
--------------------------------------------------------------------------------------------------

A dimerized version of the yeast dynein motor domain is sufficient to position microtubule asters in microfabricated chambers ([@bib31]). To understand the sufficiency of cortical dynein for generating spindle-pulling forces within a human cell, we next directly targeted dynein to the cell cortex ([Figure 3E](#fig3){ref-type="fig"}). Similar to the NuMA-RFP-Nano fusion, endogenously tagged Nano-mCherry-DHC asymmetrically accumulated at the light-illuminated region within several minutes ([Figure 3F](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1H](#fig3s1){ref-type="fig"}), and subsequently recruited SNAP-tagged endogenous p150/dynactin to this cortical region ([Figure 3F--G](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1I](#fig3s1){ref-type="fig"}). However, endogenous NuMA-SNAP was not recruited to the light illuminated region ([Figure 3H](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1I](#fig3s1){ref-type="fig"}), and the spindle was not displaced toward dynein/dynactin-enriched cortex ([Figure 3F](#fig3){ref-type="fig"} right, and [Figure 3I](#fig3){ref-type="fig"}) despite the fact that substantial levels of dynein were recruited to the cell cortex (compare [Figure 3G](#fig3){ref-type="fig"} to [Figure 1C](#fig1){ref-type="fig"}). These results suggest that cortical dynein targeting is not sufficient for generating cortical pulling forces in human cells, consistent with recent studies demonstrating that human dynein is auto-inhibited ([@bib51]; [@bib56]) and dynactin and cargo adaptors are required to activate dynein motility ([@bib37]; [@bib46]; [@bib56]). Although we cannot exclude the possibility that iLID-Nano mediated cortical targeting of DHC may impair some cortical dynein functions or assemblies in human cells, cortical dynein anchoring with ePDZ-LOVp system in *C. elegans* is also insufficient to generate cortical pulling forces ([@bib9]).

A Spindly-like motif in NuMA is required for cortical dynein recruitment, but not sufficient for spindle pulling {#s2-5}
----------------------------------------------------------------------------------------------------------------

The above results suggest that NuMA is required to activate dynein at the cell cortex. Thus, we next sought to define the minimal functional region of NuMA as a dynein adaptor ([Figure 4A](#fig4){ref-type="fig"}). Importantly, our truncation analyses revealed that the NuMA N-terminal region contains a Spindly-like motif sequence ([Figure 4B--E](#fig4){ref-type="fig"}; [Figure 4---figure supplement 1A--G](#fig4s1){ref-type="fig"}) that was recently identified as a conserved binding motif for the pointed-end complex of dynactin in dynein cargo adaptors ([@bib13]). We found that NuMA wild type (WT) fragment (1-705), but not a Spindly-motif (SpM) mutant containing alanine mutations in the Spindly-motif ([Figure 4D](#fig4){ref-type="fig"}), recruited dynein to the light-illuminated cortical region ([Figure 4F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1H](#fig4s1){ref-type="fig"}). However, the NuMA (1-705) WT and longer NuMA (1--1700) fragments were unable to fully displace the spindle despite the presence of substantial levels of cortical dynein ([Figure 4B--C,H--I](#fig4){ref-type="fig"}; [Figure 4---figure supplement 1I--L](#fig4s1){ref-type="fig"}), whereas ectopically expressed full length NuMA (1--2115 ΔNLS) was able to displace the spindle in \~40% of cells ([Figure 4G](#fig4){ref-type="fig"}; the NLS was deleted to eliminate dimerization with endogenous NuMA by spatially separating exogenously expressed constructs from the nuclear-localized endogenous NuMA before G2 release. In contrast, exogenously expressed NLS containing NuMA-RFP-Nano (1--2115) accumulated in the nucleus before G2, but was unable to displace the spindle efficiently (11.1%, n = 9), likely due to weak cortical anchorage by hetero-dimerization with endogenous NuMA lacking RFP-Nano). These results suggest that NuMA recruits dynein-dynactin via its N-terminal Spindly motif, likely to activate dynein's motility at the mitotic cell cortex similarly to other dynein cargo adaptors ([@bib13]; [@bib37]; [@bib46]). However, despite this activation, additional NuMA domains are required to produce cortical spindle-pulling forces.

![A Spindly-like motif in NuMA is required for cortical dynein recruitment, but not sufficient for spindle pulling.\
(**A**) Cortical complexes formed by light-induced targeting of NuMA fragments fused with RFP-Nano. (**B**) Full-length NuMA and the tested NuMA truncation fragments. Globular domains at N- and C-terminal regions of NuMA are indicated in light-gray and gray, respectively. (**C**) A summary of the frequency of cortical dynein recruitment and spindle displacement by targeted constructs. See [Figure 4---figure supplement 1I--J](#fig4s1){ref-type="fig"} for details. (**D**) Amino acid sequence alignment of the Spindly-motif like region of NuMA proteins in *H. Sapiens* (NP_006176), *R. norvegicus* (NP_001094161), *M. musculus* (NP_598708), *G. gallus* (NP_001177854), *X. laevis* (NP_001081559), *D. rerio* (NP_001316910), and human Spindly (NP_001316568) and Hook3 (NP_115786) aligned by ClustalWS. The conserved L and E substituted by alanine are indicated with red triangles. (**E**) Lupas coils prediction (window 21). Spindly motif (purple) is commonly located at the C-terminal region of the coiled-coil, with 200 \~ 280 residues. (**F**) Live fluorescent images of NuMA (1-705) WT (upper) and SpM mutant (lower). DHC-SNAP images are shown to the right. (**G--I**) Left: live fluorescent images of NuMA constructs (upper) and DHC-SNAP (lower). Right: kymographs obtained from image sequences of DHC-SNAP on the left at 30 s intervals. Scale bars = 10 μm.](elife-36559-fig4){#fig4}

NuMA's C-terminal microtubule-binding domains are required for spindle pulling {#s2-6}
------------------------------------------------------------------------------

At kinetochores, a multiplicity of microtubule-binding activities is required to generate cooperative pulling forces ([@bib3]; [@bib47]). Because NuMA's C-terminal region contains two microtubule-binding domains (MTBD1, and MTBD2) ([Figure 5A](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}) ([@bib1]; [@bib8]; [@bib12]; [@bib19]), direct binding of NuMA to astral microtubules may generate cooperative forces in parallel with dynein-dynactin recruitment as recently proposed by Seldin et al ([@bib48]). Consistent with this, we found that a Nano fusion with a NuMA (1--1895) fragment, which lacks both microtubule-binding domains, was unable to fully displace the spindle regardless of cortical dynein recruitment ([Figure 5B--C](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). Similarly, NuMA (1--1985), which lacks only the C-terminal microtubule-binding domain (MTBD2), was unable to displace the spindle ([Figure 5B,D](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). In contrast, NuMA Δex24, which lacks exon 24 thus disrupting MTBD1 and an NLS ([Figure 5A](#fig5){ref-type="fig"}) ([@bib12]; [@bib48]; [@bib50]), was able to recruit dynein and displace the spindle similarly to the NuMA-ΔNLS construct ([Figure 5B,E--F](#fig5){ref-type="fig"}; [Figure 4---figure supplement 1J](#fig4s1){ref-type="fig"}). Because the corresponding mouse NuMA Δex22 mutant shows spindle orientation defects in mouse keratinocytes and the epidermis ([@bib48]), this region may have specific roles in different cell types. Alternatively, weak defects in the NuMA Δex24 mutant may be suppressed by targeting increased levels of cortical NuMA Δex24 in this assay. These results indicate that NuMA's microtubule binding domains, particularly MTBD2, play critical roles for the ability of the DDN complex to generate spindle-pulling forces.

![NuMA's C-terminal microtubule-binding domains and central coiled-coil are required for spindle pulling.\
(**A**) Full-length NuMA and the tested NuMA truncation fragments. Microtubule binding domains (MTBDs) are indicated in green. (**B**) Summary of the frequency of cortical dynein recruitment, dot signal formation and spindle displacement by targeted constructs. [Figure 4---figure supplement 1I--J](#fig4s1){ref-type="fig"} for details. (**C--E**) Left: live fluorescent images of indicated NuMA constructs (upper) and DHC-SNAP (lower). Right: kymographs obtained from image sequences of DHC-SNAP on the left at 30 s intervals. (**F**) Live fluorescent images of NuMA Δex24-RFP-Nano (upper) and DHC-SNAP (lower). Expression level of NuMA Δex24-RFP-Nano was lower than that in (**E**), but the spindle was still displaced. (**G**) Left: live fluorescent images of NuMA (N + C ΔNLS)-RFP-Nano (upper) and DHC-SNAP (lower). Right: kymographs obtained from image sequences of DHC-SNAP on the left at 30 s intervals. (**H**) Enlarged images of NuMA (N + C ΔNLS)-RFP-Nano (upper) and DHC-SNAP (lower) at indicated times. (**I**) Live fluorescent images of NuMA-C-RFP-Nano (upper) and DHC-SNAP (lower). Scale bars = 10 μm.](elife-36559-fig5){#fig5}

NuMA's central coiled-coil is required for pulling on the spindle {#s2-7}
-----------------------------------------------------------------

The work described above defines two important molecular features for cortical force generation: dynein recruitment/activation through the Spindly-like motif and a distinct direct microtubule-binding activity by NuMA. To test whether these features are sufficient to generate cortical pulling forces, we next expressed a fusion construct, NuMA (N + C ΔNLS), that contains both its dynein-recruiting N-terminal and microtubule-binding C-terminal domains, but lacks a \~1000 aa region of its central coiled-coil ([Figure 5A](#fig5){ref-type="fig"} \#12). The NuMA fusion, but not the C-terminal domain (1700--2115) alone (NuMA-C), recruited DHC-SNAP to the light-illuminated region ([Figure 5G--I](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}). However, the NuMA (N + C ΔNLS) fusion was unable to fully displace the spindle ([Figure 5G](#fig5){ref-type="fig"}; [Figure 4---figure supplement 1J](#fig4s1){ref-type="fig"}). These results indicate that NuMA's 200 nm long, central coiled-coil ([@bib18]) also functions with its N-terminal and C-terminal domains to efficiently capture and pull on astral microtubules.

Identification of a clustering domain on NuMA's C-terminal region {#s2-8}
-----------------------------------------------------------------

Our results reveal that NuMA has multiple functional modules for force generation. However, considering the sophisticated kinetochore structure that surrounds a plus-end of microtubule with multiple microtubule-binding proteins ([@bib4]; [@bib7]), we next sought to define the architecture of the cortical attachment site that is required to efficiently capture and pull on dynamic plus-ends of astral microtubules. Intriguingly, we found that NuMA constructs containing its C-terminal region displayed punctate cortical signals, which tended to be even more evident in smaller constructs (e.g. [Figure 5H--I](#fig5){ref-type="fig"}). These results suggest that NuMA forms oligomeric structures at the mitotic cell cortex as observed in vitro ([@bib18]). To understand mechanisms of the NuMA's C-terminal oligomerization/clustering at the mitotic cell cortex, we took advantages of a NuMA-C 3A fragment, which eliminates CDK phosphorylation sites ([@bib5]) allowing NuMA to localize to the metaphase cell cortex independently of LGN ([@bib24]). Similar to the NuMA-C-RFP-Nano ([Figure 5I](#fig5){ref-type="fig"}), GFP-NuMA-C 3A displayed punctate cortical signals ([Figure 6A--B](#fig6){ref-type="fig"} \#C1), which was distinct from that of its cortical interacting partners - phospholipids and 4.1 proteins ([@bib24]; [@bib27]; [@bib35]; [@bib57]) -- that localize homogenously to the cell cortex ([Figure 6---figure supplement 1A--B](#fig6s1){ref-type="fig"}). Interestingly, the punctate NuMA-C 3A patterns intercalated with cortical actin localization, and still localized following the disruption of actin polymerization ([Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}). These results suggest that the NuMA C-terminal fragment self-assembles on the membrane independently of its cortical binding partners and actin cytoskeleton.

![Clustering of the DDN complex by NuMA is critical for spindle pulling.\
(**A**) GFP-tagged NuMA C-terminal fragment and the tested NuMA mutant fragments. (**B**) Live fluorescent images of nocodazole-arrested HeLa cells expressing GFP-tagged NuMA-C 3A fragments. (**C**) Amino acid sequence alignment of the clustering domain of NuMA proteins aligned by ClustalWS. Accession numbers are indicated in [Figure 4D](#fig4){ref-type="fig"}. (**D--E**) Left: live fluorescent images of indicated NuMA constructs (upper) and DHC-SNAP (lower). Right: kymographs obtained from image sequences of DHC-SNAP on the left. Asterisk in (**D**) indicates the duration in which one of the spindle poles moves away from the focal plane. Scale bars = 10 μm.](elife-36559-fig6){#fig6}

Importantly, by analyzing different truncations and mutants, we found that a 100 aa region (aa: 1700--1801) of NuMA adjacent to its 4.1 binding domain is required for the formation of punctate foci ([Figure 6A--B](#fig6){ref-type="fig"}, compare \#C1 to \#C2), and further that a highly conserved 10 amino acid region, E1768-P1777 ([Figure 6C](#fig6){ref-type="fig"}), is necessary for cluster formation ([Figure 6B](#fig6){ref-type="fig"}, see 5A-2 and 5A-3 alanine mutants; [Figure 6---figure supplement 1D--F](#fig6s1){ref-type="fig"}). Consistently, the 1700--1895 region of NuMA is required for the NuMA fragments to display punctate cortical signals (compare [Figure 4H](#fig4){ref-type="fig"} to [Figure 5C](#fig5){ref-type="fig"}; [Figure 6---figure supplement 1G](#fig6s1){ref-type="fig"}). These results suggest an exciting possibility that NuMA assembles a specialized structure to produce large spindle-pulling forces at the cell cortex.

Clustering by NuMA is required for spindle pulling and positioning, but not for spindle-pole focusing {#s2-9}
-----------------------------------------------------------------------------------------------------

Above we identified NuMA mutants (5A-2, 5A-3) that are unable to form clusters at the mitotic cell cortex ([Figure 6B--C](#fig6){ref-type="fig"}). To test the functional importance of the novel clustering behavior of NuMA, we next analyzed cortical force generation by full length NuMA wild-type (WT) compared to the 5A-3 mutant using Nano fusions. In cells expressing NuMA (1--2115 ΔNLS)-RFP-Nano (WT), NuMA and DHC-SNAP became gradually detectable as punctate foci ([Figures 6D](#fig6){ref-type="fig"}, 4:30 and 11:00), and the spindle was displaced towards the light-illuminated region ([Figures 6D](#fig6){ref-type="fig"}, 13:00). In contrast, when the NuMA 5A-3 mutant was targeted to the cell cortex, both NuMA 5A-3 mutant and DHC failed to form punctate foci ([Figure 6E](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1H](#fig6s1){ref-type="fig"}), similarly to GFP-NuMA-C 5A-3 ([Figure 6B](#fig6){ref-type="fig"}), and the spindle was not fully displaced ([Figure 5B](#fig5){ref-type="fig"} \#14, [Figure 6E](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1H](#fig6s1){ref-type="fig"}). These results indicate that NuMA's clustering activity correlates with the generation of cortical pulling forces.

To further probe functional importance of the NuMA's clustering activity, we next replaced endogenous NuMA with either NuMA WT or the 5A-3 mutant using the auxin-induced degron (AID) system ([Figure 7A](#fig7){ref-type="fig"}) ([@bib40]). Consistent with the above results, endogenous NuMA fused to mAID-mClover-FLAG tag (NuMA-mACF) displayed punctate cortical signals that colocalized with dotted signals of SNAP-tagged dynein and LGN ([Figure 7---figure supplement 1A--C](#fig7s1){ref-type="fig"}). When the endogenous NuMA-mACF was degraded, 80% of mitotic cells (n = 63) displayed abnormal spindles with unfocused microtubules ([Figure 7B](#fig7){ref-type="fig"} \#2; [Figure 7---figure supplement 1D--E](#fig7s1){ref-type="fig"}), consistent with the NuMA KO phenotypes in human hTERT-RPE1 cells ([@bib20]). However, both NuMA WT and the 5A-3 mutant were able to rescue these abnormal spindle phenotypes ([Figure 7B](#fig7){ref-type="fig"} \#3 and \#4), suggesting that clustering of NuMA is dispensable for microtubule focusing at the spindle poles. In contrast, when endogenous NuMA was replaced with NuMA 5A-3 mutant, the metaphase spindle was tilted and randomly oriented on the x-z plane (26.8 ± 20.7°, n = 37, [Figure 7C](#fig7){ref-type="fig"}; [Figure 7---figure supplement 1F](#fig7s1){ref-type="fig"}) whereas the spindle in NuMA WT cells was oriented parallel to the substrate (10.7 ± 9.6°, n = 34, [Figure 7C](#fig7){ref-type="fig"}) as observed in control metaphase cells (11.5 ± 11.8°, n = 41, [Figure 7C](#fig7){ref-type="fig"}). These results suggest that NuMA's C-terminal clustering is required for proper spindle orientation. We note that the 5A-3 mutation site contains Y1774 ([Figure 6C](#fig6){ref-type="fig"}), which is phosphorylated by ABL1 kinase and contributes to proper spindle orientation ([@bib34]). However, treatment with the ABL1 kinase inhibitor Imatinib caused only a mild spindle orientation phenotype (12.3 ± 14.7°, n = 27, [Figure 7C](#fig7){ref-type="fig"}), suggesting that the spindle mis-orientation phenotype observed in the 5A-3 mutant is largely attributable to defects in NuMA clustering. Taken together, these results indicate that clustering activity of NuMA is required at the mitotic cell cortex, but not at the spindle poles, for generating cortical pulling forces. Thus, NuMA has a location-dependent structural function that clusters multiple DDN complexes to efficiently capture and pull on dynamic plus ends of astral microtubules.

![Clustering activity of NuMA is required for spindle positioning, but not for spindle pole focusing.\
(**A**) Diagram summarizing auxin inducible degradation (AID) system ([@bib40]). In the presence of OsTIR1 and auxin (IAA), mAID fusion proteins are rapidly degraded upon poly-ubiquitylation by proteasome. Because RNAi-mediated depletion of NuMA is insufficient to completely deplete NuMA proteins even after 72 hr ([@bib24]), we sought to degrade endogenous NuMA using the auxin-induced degron technology. (**B**) Left: metaphase NuMA-mACF cell lines showing live fluorescent images of NuMA-mACF, mCherry-NuMA WT, or 5A3 mutant, and SiR-tubulin (SiR-TUB) after 24 hr following the treatment of Dox and IAA. The degradation of endogenous NuMA-mACF was induced by the treatment with Dox and IAA. The expression of mCherry-NuMA WT or 5A-3 was also induced by the Dox treatment. Right: histogram showing frequency of the focused bipolar spindle in each condition. \* indicates statistical significance according to a Student's *t*-test (p\<0.0001). Error bars indicate SEM; n \> 25, from three independent experiments. (**C**) Left: orthogonal views of the metaphase spindle on the x-y (top) and x-z (bottom) plane. In each case, endogenous NuMA was replaced with either mCherry-NuMA WT or 5A-3. Right: scatterplots of the spindle orientation on the x-z plane. Red lines indicate mean ± SD; n \> 27, from three independent experiments. (**D**) Model showing multiple-arm capture and pulling of an astral microtubule by the cortical DDN cluster. Scale bars = 10 μm.](elife-36559-fig7){#fig7}

Discussion {#s3}
==========

The cortical DDN complex acts as a core functional unit of the cortical force-generating machinery {#s3-1}
--------------------------------------------------------------------------------------------------

Here, we applied a light-induced targeting system, iLID ([@bib17]), for *in cell* reconstitution of the cortical force-generating machinery (e.g. [Figure 1A--B](#fig1){ref-type="fig"}). Our work demonstrates that light-induced targeting of NuMA, but not dynein, is sufficient to control spindle position and orientation in human cells. This is consistent with recent findings that mammalian dynein requires cargo adaptors to activate its motility in vitro ([@bib37]; [@bib46]; [@bib56]). In addition, our findings suggest that LGN/Gαi are dispensable for force generation, and instead act as receptors that specify the position of NuMA at the cell membrane. Consistent with this model, LGN-independent pathways that target NuMA to the cell cortex have been reported, such as Dishevelled ([@bib49]) and phospho-lipids ([@bib57]). Thus, we propose that the Dynein-Dynactin-NuMA (DDN) complex is a universal core unit that constitutes the cortical force-generating machinery, whereas LGN and other receptors specify the targeting of the DDN complex to the membrane.

NuMA acts as a force-amplifying platform at the mitotic cell cortex {#s3-2}
-------------------------------------------------------------------

Our work demonstrates four distinct functions for NuMA at the mitotic cell cortex. First, NuMA recruits dynein-dynactin through its N-terminal region. We found that the conserved Spindly-like motif in NuMA is required for dynein recruitment ([Figure 4D--F](#fig4){ref-type="fig"}). NuMA may directly interact with the dynactin pointed-end complex through this Spindly-like motif similarly to other dynein cargo adaptors ([@bib13]), and activate dynein motility at the mitotic cell cortex. Second, the central long coiled-coil of NuMA is required for spindle pulling ([Figure 5G](#fig5){ref-type="fig"}). Purified NuMA displays a long (\~200 nm) rod-shaped structure that shows flexibility with a main flexible-linker region near the middle of central coiled coil ([@bib18]). Longer flexible arms of NuMA may increase the efficiency of astral microtubule capture by the dynein-dynactin complex, similarly to fibril-like Ndc80 complexes and CENP-E motors at kinetochores ([@bib22]; [@bib36]). Third, NuMA contributes to cortical force generation with its own C-terminal microtubule-binding domains (MTBDs) ([Figure 5C](#fig5){ref-type="fig"}), particularly MTBD2 ([Figure 5D](#fig5){ref-type="fig"}). Because this region is also required to prevent hyper-clustering ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"} right), and is sufficient for cortical localization in anaphase ([Figure 6---figure supplement 1F](#fig6s1){ref-type="fig"} C\#3, T.K. unpublished observation), this region may play multiple roles for cortical pulling-force generation. Interestingly, a NuMA C-terminal fragment containing MTBD1 (aa: 1811--1985, called NuMA-TIP, [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}) accumulates at microtubule tips, and remains associated with stalled and/or deploymerizing microtubules ([@bib48]). By using its two microtubule-binding domains, NuMA may harness the energy of microtubule depolymerization for pulling on astral microtubules similar to the human Ska1 complex or yeast Dam1 ring complex at kinetochores, both of which track with depolymerizing microtubules ([@bib47]; [@bib54]).

Finally, we demonstrate that NuMA generates large pulling forces by clustering the DDN complexes through its C-terminal clustering domain ([Figure 6C--E](#fig6){ref-type="fig"}), similar to lipid microdomains on phagosomes that achieve cooperative force generation of dynein ([@bib41]). Previous studies demonstrated that the 1700--2003 region of NuMA is required for oligomerization in vitro ([@bib18]). We defined the 1700--1801 region of NuMA as a clustering domain (CD) required for clustering of NuMA-C 3A, and found that the CD containing 1700--1895 region of NuMA is sufficient for NuMA fragments to form clusters at the mitotic cell cortex when targeted as a Nano fusion ([Figure 4H](#fig4){ref-type="fig"} and [Figure 5C](#fig5){ref-type="fig"}). Because this 1700--1895 fragment itself localizes to the cytoplasm, and showed no punctate signals ([Figure 6---figure supplement 1D and G](#fig6s1){ref-type="fig"} \#C6), the clustering activity of this region may be enhanced by its recruitment and concentration at membranes, as observed for CRY2 clusters ([@bib2]). Consistently, NuMA's clustering function is required for spindle pulling at the cell cortex ([Figure 6E](#fig6){ref-type="fig"} and [Figure 7C](#fig7){ref-type="fig"}), but not for microtubule focusing at spindle poles ([Figure 7B](#fig7){ref-type="fig"}).

Interestingly, spindle pole focusing requires both NuMA's C-terminal microtubule binding and N-terminal dynein-dynactin binding modules, but not its central long coiled-coil ([@bib20]). Whereas NuMA-dynein complexes generate active forces within cells, NuMA's multiple modules appear to be differently utilized depending on the context.

Mechanisms of astral-microtubule capture and pulling by the cortical DDN clusters {#s3-3}
---------------------------------------------------------------------------------

Our live-cell imaging revealed that DDN clusters gradually assemble at the cell cortex and then displace the spindle ([Figures 5H](#fig5){ref-type="fig"} and [6D](#fig6){ref-type="fig"}). Based on the results obtained in this study, we propose a multiple-arm capture model of astral microtubules by the DDN clusters ([Figure 7D](#fig7){ref-type="fig"}; [Figure 7---figure supplement 1G](#fig7s1){ref-type="fig"}). Following nuclear envelope break down, cytoplasmic NuMA and DDN complexes are recruited to the mitotic cell cortex by binding to the LGN/Gαi complex, and then assemble DDN clusters on the cell cortex via the NuMA C-terminal domain. In vitro, up to 10--12 NuMA dimers self-assemble and form ring-like structures with an average diameter of 48 ± 8 nm ([@bib18]) ([Figure 7---figure supplement 1G](#fig7s1){ref-type="fig"}), which are similar to those of the central hub of yeast kinetochores (37 ± 3 nm) ([@bib14]), and of the Dam1 ring complex (about 50 nm) which encircles a single kinetochore microtubule ([@bib38]; [@bib53]). Given that the NuMA MTBD interacts with depolymerizing microtubules ([@bib48]), dynein-dynactin moves along the lattice of microtubules, and astral microtubules tends to interact with the cell cortex through an end-on configuration in pre-anaphase cells ([@bib29]; [@bib30]; [@bib44]), it is tempting to speculate that the DDN cluster encircles or partially wrap the plus tip of a single astral microtubule with NuMA's MTBDs, and holds the lateral wall of the astral microtubule with multiple dynein/dynactin-containing arms ([Figure 7D](#fig7){ref-type="fig"}; [Figure 7---figure supplement 1G](#fig7s1){ref-type="fig"}). Future work using super-resolution imaging and in vitro reconstitution will reveal the precise architecture of the interaction between astral microtubule tips and the cortical DDN cluster. This multiple-arm capture by the DDN cluster leads to larger cooperative pulling forces by increasing the number of both dynein-dynactin containing modules and NuMA's microtubule binding per an astral microtubule. Additionally, this clustering may contribute to force generation by increasing both the stability of the DDN complex at the membrane, and the frequency for dynein-dynactin to capture or re-bind to astral microtubules. Alternatively, astral microtubule binding of the DDN complex may also assist cluster formation on the cell cortex. To produce pulling forces at dynamic plus-ends of microtubules, the cortical force-generating machinery appears to develop multiple molecular and structural features analogous to the kinetochore ([@bib4]; [@bib7]).

In conclusion, our optogenetic reconstitution and AID-mediated replacement reveal that the cortical DDN cluster acts as a core spindle-pulling machinery in human cells. Analyzing the structure and regulation of the DDN cluster will provide further information to understand the basis of spindle positioning in both symmetric and asymmetric cell division, and the general principles for microtubule plus-end capture and pulling.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\   Designation            Source or reference        Identifiers                                                        Additional information
  or resource                                                                                                                                    
  ------------------------- ---------------------- -------------------------- ------------------------------------------------------------------ -------------------------
  Chemical compound,\       SiR-tubulin            Spirochrome                Cat\# SC002                                                        50 nM
  drug                                                                                                                                           

  Chemical compound,\       SiR-DNA                Spirochrome                Cat\# SC007                                                        20 nM
  drug                                                                                                                                           

  Chemical compound,\       SiR-actin              Spirochrome                Cat\# SC001                                                        50 nM
  drug                                                                                                                                           

  Chemical compound,\       SNAP Cell 647-SiR      New England BioLabs        Cat\# S9102S                                                       0.1 μM
  drug                                                                                                                                           

  Chemical compound,\       SNAP Cell TMR-star     New England BioLabs        Cat\# S9105S                                                       0.1 μM
  drug                                                                                                                                           

  Chemical compound,\       Hoechst 33342          Sigma-Aldrich              Cat\# B2261                                                        50 ng/mL
  drug                                                                                                                                           

  Chemical compound,\       Nocodazole             Sigma-Aldrich              Cat\# M1404                                                        330 nM (high dose) for\
  drug                                                                                                                                           18--24 hr and 30 nM\
                                                                                                                                                 (low dose) for 1--4 hr

  Chemical compound,\       Paclitaxel             Sigma-Aldrich              Cat\# T7402                                                        10 μM
  drug                                                                                                                                           

  Chemical compound,\       Cytochalasin D         Sigma-Aldrich              Cat\# C8273                                                        1 μM
  drug                                                                                                                                           

  Chemical compound,\       MG132                  Sigma-Aldrich              Cat\# C2211                                                        20 μM
  drug                                                                                                                                           

  Chemical compound,\       RO-3306                Sigma-Aldrich              Cat\# SML0569                                                      9 μM
  drug                                                                                                                                           

  Chemical compound,\       Imatinib mesylate      Sigma-Aldrich              Cat\# SML1027                                                      10 μM for 24 hr
  drug                                                                                                                                           

  Chemical compound,\       Ciliobrevin D          Calbiochem                 Cat\# 250401                                                       75 μM
  drug                                                                                                                                           

  Chemical compound,\       Puromycin\             Wako Pure Chemical\        Cat\# 160--23151                                                   1 μg/mL
  drug                      dihydrochloride        Industries                                                                                    

  Chemical compound,\       G-418 solution         Roche                      Cat\# 04727894001                                                  800 μg/mL
  drug                                                                                                                                           

  Chemical compound,\       Hygromycin B           Wako Pure Chemical\        Cat\# 084--07681                                                   200 μg/mL
  drug                                             Industries                                                                                    

  Chemical compound,\       Blasticidin S\         Funakoshi Biotech          Cat\# KK-400                                                       8 μg/mL
  drug                      hydrochloride                                                                                                        

  Chemical compound,\       Doxycycline hyclate    Sigma-Aldrich              Cat \# D9891                                                       2 μg/mL
  drug                                                                                                                                           

  Chemical compound,\       3-Indoleacetic acid\   Wako Pure Chemical\        Cat \# 098--00181                                                  500 μM
  drug                      (IAA)                  Industries                                                                                    

  Chemical compound,\       DirectPCR (cell)       Viagen Biotech             Cat \#302 C                                                        
  drug                                                                                                                                           

  Antibody                  Anti-a-tubulin\        Sigma-Aldrich              Cat\# T9026                                                        1:2000
                            (clone DM1A)                                                                                                         

  Antibody                  Rabbit polyclonal\     Abcam                      Cat\# ab36999\                                                     1:1000
                            anti-NuMA                                         (RRID:[AB_776885](https://scicrunch.org/resolver/AB_776885))       

  Antibody                  Rabbit polyclonal\     Santa Cruz\                Cat\# sc-9115                                                      1:500
                            anti-DHC               Biotechnology                                                                                 

  Antibody                  Mouse monoclonal\      BD Transduction\           Cat\# 610473                                                       1:1000
                            anti-p150              Laboratories                                                                                  

  Antibody                  Rabbit polyclonal\     BETHYL Laboratories        Cat\# A303-032A\                                                   1:2000
                            anti-LGN                                          (RRID:[AB_10749181](https://scicrunch.org/resolver/AB_10749181))   

  Antibody                  Mouse monoclonal\      Santa Cruz Biotechnology   Cat\# sc-56536                                                     1:100
                            anti-Gαi-1                                                                                                           

  Antibody                  Rabbit polyclonal\     New England BioLabs        Cat\# P9310S                                                       1:1000
                            anti-SNAP                                                                                                            

  Antibody                  Rabbit polyclonal\     Kanemaki Laboratory\       In-house antibody                                                  1:1000
                            anti-OsTIR1            ([@bib40])                                                                                    

  Antibody                  Rabbit polyclonal\     Abcam                      Cat\# ab5176-25                                                    1:500
                            anti-phospho S10\                                                                                                    
                            histone H3                                                                                                           

  Antibody                  Sheep anti-mouse\      GE Healthcare              Cat\# NA931                                                        1:10,000
                            IgG-HRP                                                                                                              

  Antibody                  Donkey anti-rabbit\    GE Healthcare              Cat\# NA934                                                        1:10,000
                            IgG-HRP                                                                                                              

  Software, algorithm       Photoshop CS5,\        Adobe Systems              <http://www.adobe.com>                                             
                            version 12.0                                                                                                         

  Software, algorithm       Fiji                   ([@bib45])                 <https://fiji.sc/>                                                 

  Software, algorithm       Metamorph              Molecular Devices          <https://www.moleculardevices.com>                                 

  Software, algorithm       GraphPad Prism 6,\     GraphPad Software          <https://www.graphpad.com>                                         
                            version 6.0 c                                                                                                        

  Software, algorithm       Excel                  Microsoft                  <https://products.office.com/>                                     
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Plasmid construction {#s4-1}
--------------------

Plasmids for CRISPR/Cas9-mediated genome editing were constructed according to the protocol described in Natsume et al., ([@bib40]). To construct CRISPR/Cas9 vectors, pX330-U6-Chimeric_BB-CBh-hSpCas9 (\#42230, Addgene, Cambridge, MA) was used ([@bib42]). PAM and 20 bp single guide RNA sequences were selected by the optimized CRISPR design tool (<http://crispr.mit.edu>) ([Supplementary File 2](#supp2){ref-type="supplementary-material"}). To construct donor plasmids containing homology arms for NuMA (\~500 bp homology arms), p150 (\~200 bp arms) and DHC (N-terminal,\~500 bp arms), a gene synthesis service (Genewiz, South Plainsfield, NJ) was used. To construct the donor plasmid for DHC (C-terminal), a \~2,000 bp sequence was amplified by PCR from genomic DNA and then cloned into the pCR2.1-TOPO vector. A BamHI site was introduced at the center of the 2,000 bp fragment to facilitate the subsequent introduction of cassettes encoding tag and selection marker genes. To express Mem-BFP-iLID from the AAVS1 locus, membrane-targeted BFP2 ('Mem' from Neuromodulin; Clontech, Mountain View, CA) was fused to the N-terminus of iLID (\#60411, Addgene) with a 53-amino acid (aa) linker derived from pIC194 ([@bib23]) (\#44433, Addgene), and the resulting fusion construct was introduced between the AfeI and HindIII sites in pMK231 (AAVS1 CMV-MCS-Puro, \#105924, Addgene). Note that the Venus-iLID-caax construct (\#60411, Addgene) was able to recruit RFP-Nano, but not NuMA-RFP-Nano to the membrane. To construct the RFP-Nano-NeoR cassette, a tagRFPt-Nano fragment (\#60415, Addgene) was introduced between the SacI and MfeI sites in pMK277 (\#72793, Addgene). The RFP-Nano-NeoR cassette was excised by BamHI and cloned into the BamHI site in the donor plasmid containing NuMA's homology arms. A 24-aa linker sequence containing 4 × GGGS was introduced between the last codon of NuMA and the first codon of RFP. To construct the Nano-mCherry cassette, the Nano coding sequence was fused to the N-terminal region of mCherry from pIC194 with a 2 × GGGS linker. To express Nano-mCherry-DHC, the BSDR sequence from pIC242 ([@bib23]) (\#44432, Addgene) was linked to the Nano-mCherry sequence with a P2A sequence, and the resulting BSDR-P2A-Nano-mCherry cassette, which contained a BamHI site at each end, was inserted into the BamHI site of the donor plasmid for DHC (N-terminal). A 47-aa linker sequence derived from pIC 194 was introduced between the last codon of mCherry and the start codon of DHC. To generate the SNAP-HygroR cassette, the mCherry coding sequence in pMK281 (\#72797, Addgene) was replaced with the SNAP~f~ coding sequence (N9186, New England BioLabs, Ipswich, MA) using In-Fusion^®^ cloning (Takara Bio, Ōtsu, Japan). The SNAP-HygroR cassette was excised by BamHI and cloned into the BamHI site of the donor plasmids. To make the DHC donor plasmid containing a SNAP-BSDR cassette, HygroR of the SNAP-HygroR cassette was replaced with BSDR from pIC242 using In-Fusion^®^ cloning. To conditionally express NuMA-RFP-Nano constructs from the Rosa 26 locus, a fragment containing Tet-On 3G, the TRE3GS promoter, and a multiple cloning site (MCS) derived from pMK240 (Tet-On-AAVS1-MCS-PuroR, \#105925, Addgene) was introduced into pMK247 (Rosa26-CMV-MCS-HygroR, \#105926, Addgene), which contains homology arms for the Rosa 26 locus. An RFP-Nano coding sequence was integrated between MluI and AgeI in the MCS, and NuMA fragments were subsequently inserted into the MluI site. NuMA truncation fragments and mutants were generated by PCR using NuMA cDNA ([@bib5]; [@bib23]) as a template, and the sequences were confirmed by DNA sequencing. These NuMA fragments encode isoform 2 (aa: 1--2101), which lacks a 14-aa region (aa: 1539--1552) in the longer isoform 1. However, the human NuMA constructs presented in the present study conform to isoform 1 (aa: 1--2115; NP_006176) to avoid confusion.

To construct mAID-mClover-3×FLAG NeoR, a 3 × FLAG sequence with a GGGS linker was introduced at the C-terminus of mClover of pMK289 (\#72827, Addgene) by PCR. To conditionally express mCherry-NuMA WT or the 5A-3 construct from Rosa 26 locus, a fragment containing the TRE3GS promoter and the MCS derived from pMK240 was introduced into pMK247. The mCherry coding sequence derived from pIC 194 was integrated between the MluI and AgeI sites in the MCS, and the NuMA fragments were subsequently inserted Between the SalI and AgeI site.

Cell culture and cell line generation {#s4-2}
-------------------------------------

HCT116 and HeLa cells were cultured as described previously ([@bib23]; [@bib40]; [@bib52]). No mycoplasma contamination was detected by MycoAlert Mycoplasma Detection Kit (Lonza). Knock-in cell lines were generated according to the procedures described in Natsume et al., ([@bib40]) with minor modifications. CRISPR/Cas9 and donor plasmids were transfected into the cell lines using Effectene (Qiagen, Venlo, Netherlands). For drug selection, 1 μg/mL puromycin (Wako Pure Chemical Industries, Osaka, Japan), 800 μg/mL G418 (Roche, Basel, Switzerland), 200 μg/mL hygromycin B (Wako Pure Chemical Industries), and 8 μg/mL blasticidin S hydrochloride (Funakoshi Biotech, Tokyo, Japan) were used. Selection medium was replaced with fresh selection medium 4--5 days after starting selection. After 10--14 days, colonies grown on a 10 cm culture dish were washed once with PBS, picked up with a pipette tip under a microscope (EVOS XL, Thermo Fisher Scientific, Waltham, MA) located on a clean bench, and subsequently transferred to a 96-well plate containing 50 μL of trypsin-EDTA. After a few minutes, these trypsinized cells were transferred to a 24-well plate containing 500 μL of the selection medium, and then further transferred to a 96-well plate (200 μL per well) for the preparation of genomic DNA. The remaining cells in the 24-well plate were grown and frozen using Bambanker Direct (Nippon Genetics, Tokyo, Japan). For the preparation of genomic DNA, cells in the 96-well plate were washed once with PBS and then mixed with 60 μL of DirectPCR^®^ lysis solution (Viagen Biotech, Los Angeles, CA) containing 0.5 mg/mL proteinase K (Wako Pure Chemical Industries). The 96-well plate was sealed with an aluminum plate seal and incubated first at 56°C for 5--6 hr, then at 80°C for 2--3 hr in a water bath. To confirm the genomic insertion, PCR was performed using 1--2 μL of the genomic DNA solution and Tks Gflex DNA polymerase (Takara Bio). The cell lines and primers used in this study are listed in [Supplementary Files 1](#supp1){ref-type="supplementary-material"} and [3](#supp3){ref-type="supplementary-material"}, respectively.

Antibodies against tubulin (DM1A, Sigma-Aldrich, 1:2,000), NuMA (Abcam, 1:1,000), DHC (Santa Cruz Biotechnology, 1:500), p150 (BD Transduction Laboratories, 1:1,000), SNAP (New England BioLabs, 1:1,000), LGN (BETHYL Laboratories, 1:2,000), Gαi-1 (Santa Cruz Biotechnology, 1:100), OsTIR1 (Kanemaki Laboratory, 1:1,000), and H3S10P (Abcam, 1:500) were used for western blotting.

Microscope system {#s4-3}
-----------------

Imaging was performed using spinning-disc confocal microscopy with a 60 × 1.40 numerical aperture objective lens (Plan Apo λ, Nikon, Tokyo, Japan). A CSU-W1 confocal unit (Yokogawa Electric Corporation, Tokyo, Japan) with three lasers (488, 561, and 640 nm, Coherent, Santa Clara, CA) and an ORCA-Flash4.0 digital CMOS camera (Hamamatsu Photonics, Hamamatsu City, Japan) were attached to an ECLIPSE Ti-E inverted microscope (Nikon) with a perfect focus system. A stage-top incubator (Tokai Hit, Fujinomiya, Japan) was used to maintain the same conditions used for cell culture (37°C and 5% CO~2~). For light illumination, a Mosaic-3 digital mirror device (Andor Technology, Belfast, UK) and a 488 nm laser (Coherent) were used. The microscope and attached devices were controlled using Metamorph (Molecular Devices, Sunnyvale, CA).

Immunofluorescence and live cell imaging {#s4-4}
----------------------------------------

For immunofluorescence in [Figure 2A](#fig2){ref-type="fig"}, cells were fixed with PBS containing 3% paraformaldehyde and 2% sucrose for 10 min at room temperature. Fixed cells were permeabilized with 0.5% Triton X-100 for 5 min on ice, and pretreated with PBS containing 1% BSA for 10 min at room temperature after washing with PBS. Microtubules and DNA were visualized using 1:1000 anti-α-tubulin antibody (DM1A, Sigma-Aldrich, St. Louis, MO) and 1:5000 SiR-DNA (Spirochrome), respectively. Images of multiple z-sections were acquired by spinning-disc confocal microscopy using 0.2 μm spacing and camera binning 1. Maximally projected images from 15 z-sections were generated with Metamorph.

For time-lapse imaging of living cells, cells were cultured on glass-bottomed dishes (CELLview, \#627870, Greiner Bio-One, Kremsmünster, Austria) and maintained in a stage-top incubator (Tokai Hit) to maintain the same conditions used for cell culture (37°C and 5% CO~2~). Three z-section images using 0.5 μm spacing were acquired every 30 s with camera binning 2. Maximally projected z-stack images were shown in figures unless otherwise specified. Microtubules and actin were stained with 50 nM SiR-tubulin and 50 nM SiR-actin (Spirochrome), respectively, for \>1 hr prior to image acquisition. DNA was stained either 20 nM SiR-DNA (Spirochrome) or 50 ng/mL Hoechst 33342 (Sigma-Aldrich) for \>1 hr before observation. To visualize SNAP-tagged proteins, cells were incubated with 0.1 μM SNAP-Cell 647 SiR or TMR-STAR (New England BioLabs) for \>2 hr, and those chemical probes were removed before observation.

For drug treatment, cells were incubated with drugs at the following concentrations and duration: nocodazole, 330 nM (high dose) for 18--24 hr and 30 nM (low dose) for 1--4 hr; paclitaxel, 10 μM for 1--10 min; cytochalasin D, 1 μM for 1--10 min; MG132, 20 μM for 1--4 hr ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}); RO-3306, 9 μM for 20 hr; imatinib, 10 μM for 24 hr ([@bib34]); doxycycline hyclate (Dox), 2 μg/mL ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}); Ciliobrevin D, 75 μM.

To express NuMA-RFP-Nano constructs from the Rosa 26 locus in LGN-depleted cells, cells were treated with LGN siRNA ([@bib23]) and Dox at 24 hr and 48 hr, respectively, according to the procedure described in [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}. RO-3306 was added at 48 hr to cells that were then synchronized at G2 at 68 hr. The NuMA-RFP-Nano fusion protein was expressed in most cells, but its expression frequency was reduced in cells that expressed longer NuMA fragments. siRNAs targeting Gαi-1 isoforms ([@bib23]) were obtained from Dhamacon.

To compare the intensities of cortically targeted NuMA-Nano fusions, images of NuMA-Nano fusions and DHC-SNAP were acquired using the same parameters (Exposure time: NuMA, 1000 msec; DHC, 500 msec), except for [Figure 1B](#fig1){ref-type="fig"} (NuMA, 1500 msec; DHC, 500 msec). To optimize image brightness, same linear adjustments were applied using Fiji and Photoshop. Supplemental movie files were generated using Metamorph and Fiji.

To activate the auxin-inducible degradation of NuMA-mAID-mClover-3FLAG (mACF), cells were treated with 2 μg/mL Dox and 500 μM indoleacetic acid (IAA) for 20--24 hr. Cells with undetectable mClover signals were analyzed. A small population of cells showed mClover signals even after being treated with Dox and IAA. For replacement experiments, either mCherry-NuMA WT or the 5A-3 mutant was expressed from the Rosa 26 locus following Dox treatment. This caused the cells to simultaneously express OsTIR1 from the AAVS1 locus to initiate the auxin-inducible degradation of endogenous NuMA-mACF.

Light-inducible targeting {#s4-5}
-------------------------

Except for [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}, HCT116 cells expressing Mem-BFP-iLID and NuMA-Nano fusion proteins were treated with RO-3306 and MG-132 according to the procedure described in [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"} to increase the proportion of metaphase-arrested cells.

To target Nano fusion proteins at the metaphase cell cortex, cells were illuminated using a Mosaic-3 digital mirror device (Andor Technology) at the indicated regions (circles with a diameter of 1.95 μm for [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}, and that of 2.82 μm for other figures) with a 488 nm laser pulse (500 msec exposure, 25 mW). To manually control the frequency of the light pulse and the position of the illuminated region during time-lapse experiments, a custom macro was developed using Metamorph. Using this macro, indicated regions were illuminated \~10 times with the light pulse during time intervals (30 s) between image acquisitions. The illuminated position was adjusted to precisely illuminate the cortical region of each cell. In response to the expression level of the Nano fusion proteins, the frequency of the light pulse was reduced to prevent the targeting of Nano fusion proteins throughout the cell cortex.

To reposition NuMA-RFP-Nano at the mitotic cell cortex in [Figure 1F,](#fig1){ref-type="fig"} a cortical region adjacent to the spindle axis was illuminated. The light-illuminated region was changed once the spindle started to move but before the spindle was completely attached to the cell cortex. Spindles that rotated by approximately 90° within 15 min were counted.

Quantification of cortical fluorescent signals and spindle displacement {#s4-6}
-----------------------------------------------------------------------

Cortical and cytoplasmic fluorescence intensities were determined using Fiji by calculating the mean pixel intensity along three different straight lines (length 3 μm, width three pixels) drawn along the cell cortex showing Nano signals or the cytoplasm near the cell cortex but without any aggregations. The background intensity was subtracted from each measurement. The distance from the pole to the cell cortex was measured using Metamorph or Fiji. Line scans for cortical fluorescence intensity were generated using Fiji by calculating the mean pixel intensity along the segmented line (width three pixels) drawn along the cell cortex. Kymographs were generated using Photoshop (Adobe Systems, San Jose, CA).

Spindle displacement was judged by the definition given in [Figure 4---figure supplement 1I](#fig4s1){ref-type="fig"}. In addition, cells that satisfied the following conditions were analyzed; (1) NuMA-RFP-Nano fusion proteins were asymmetrically recruited at the light-illuminated region, but not distributed to a whole cell cortex. (2) The cortical intensities of NuMA-Nano fusion proteins were higher than that of NuMA Δex24-RFP-Nano ([Figure 5F](#fig5){ref-type="fig"}). (3) DHC-SNAP was detectable at the light-illuminated region except for the case of the cortical targeting of NuMA-C (\#13). (4) The spindle was monitored for \>10 min, and not vertically rotated. (5) The bipolar spindle was properly formed without severe membrane blebbing.

Statistical analysis {#s4-7}
--------------------

To determine the significance of differences between the mean values obtained for two experimental conditions, Student's *t*-tests or Mann-Whitney tests (Prism 6; GraphPad Software, La Jolla, CA) were used as indicated in the figure legends.
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Decision letter
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Reviewing Editor
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Dynein-Dynactin-NuMA clusters generate cortical spindle-pulling forces as a multi-arm ensemble\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Andrea Musacchio as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

All three reviewers were strongly supportive of your manuscript. You use of an elegant optogenetics approach to systematically dissect the molecular requirements for dynein-mediated cortical pulling on astral microtubules, which determines the position of mitotic spindles. Direct light-induced targeting of NuMA to the cortex bypasses the requirement for NuMA\'s cortical receptor LGN and allows the precise definition of the domains and motifs in NuMA required for dynein-dynactin recruitment and cortical force generation. The generation of the innovative experimental toolbox is carefully documented, and the technical standard of the experiments is high.

Using these tools, with proteins at endogenous levels, you dynamically control spindle position and orientation. You determine that astral microtubule depolymerization is not required for pulling, and test the function of a large panel of NuMA truncations and mutants. You also identify a motif in NuMA\'s N-terminus that is required for cortical dynein recruitment, and show that a motif in NuMA\'s C-terminus is required for the punctate foci of NuMA and dynein seen at the cell cortex. Mutations that prevent the formation of punctate foci also prevent cortical pulling, so you conclude that NuMA-mediated clustering of dynein-dynactin-NuMA is required for cortical pulling and spindle positioning. This is a conceptually novel point and constitutes the main advance of the paper.

In addition, this work opens questions on NuMA\'s multimeric organization (e.g., the regulation and function of oligomerization at the cortex vs. within the spindle), and it provides insight into the big picture question of how active forces within cells are spatially organized. The work is characterized by careful experimental design and thorough controls, and the manuscript and figures are clear and well presented (with helpful schematics and organization).

Essential revisions:

Experimental:

The reviewers ask for two pieces of experimental data. The first needs to be addressed if possible. The second would clearly add to the paper, but the reviewer leaves it up to you as to whether you want to include it -- if not then you should address the reviewers questions.

1\) Most of the experiments presented are conducted in an LGN silenced background, thus it seems that pulling forces do not require LGN nor Gαi. For the sake of completeness, it would be beneficial to show LGN levels at the end of the experiments, i.e. after 72 hours from siRNA treatment, and at the same time test the effect of removing Gαi.

2\) Dynein-dynactin recruitment requires a Spindly-like motif in NuMA\'s N-terminal region. This is an intriguing finding that suggests mechanistic similarities between functionally diverse dynein adaptors. However, the authors also show that NuMA\'s N-terminal region is not sufficient for cortical force generation. This raises the question of how good NuMA\'s N-terminal region really is at activating dynein. For comparison, it might be interesting to check whether cortical targeting of the N-terminal BICD2 region, which robustly activates dynein-dynactin motility in vitro and in vivo, is sufficient for force generation in this assay.

Manuscript revisions:

The reviewers have also identified a number of points that need clarification in order to improve the manuscript. I attach the list of these below. Please address these points in your response to the reviewers and make changes to the manuscript where appropriate.

Reviewer \#1:

\- Robust spindle displacement is observed after addition of taxol (Figure 2). This is surprising given the end-on microtubule binding by NuMA clusters proposed by authors, which requires shortening of microtubules to pull the spindle towards the cortex. The authors should comment on how the taxol result is compatible with their model.

\- The authors show that direct targeting of dynein to the cortex (which also results in dynactin recruitment) is not sufficient per se for the generation of cortical pulling forces and that cortical force generation requires the second microtubule binding domain of NuMA. These findings are in agreement with the results of Seldin, Muroyama, and Lechler (2016), who showed that the microtubule-binding activity of NuMA is required for mitotic spindle positioning in cultured mouse keratinocytes and the epidermis. This should be explicitly acknowledged by the authors.

\- The generation of cortical pulling forces requires the central coiled-coil region of NuMA. This contrasts with the observation that the same NuMA region is dispensable for spindle pole focusing, as shown by Hueschen et al. (*eLife* 2017). The context-dependent requirement for NuMA\'s central coiled-coil region is interesting and should be commented on.

\- The generation of cortical pulling forces requires clustering of NuMA at the cortex, which is mediated by a highly conserved patch in NuMA\'s C-terminal region. This is perhaps the most important conclusion of this study and suggests a mechanism similar to the one used by the kinetochore, where multiple microtubule-binding activities are concentrated for stable end-on attachment. The authors should clarify the following points: does NuMA clustering occur independently of astral microtubules? In the model (Figure 7D), LGN clusters with NuMA -- but is there evidence for this?

\- Figure 4C: the number of cells examined in the \'spindle displacement\' assay for NuMA fragments \#3 and \#6 is too low (2 and 3, respectively).

Reviewer \#2:

\- The light-induced system adopted in the article enables local recruitment of NuMA-RFP-Nano (or Dynein-RFP-Nano) to the cortex by hetero-dimerization of the fusion proteins with activated membrane-bound iLID. It is known that NuMA cortical levels are critical in determining the extent of spindle pulling forces. What are the levels of NuMA-RFP-Nano and Dynein-RFP-Nano recruited at the cortex upon light induction compared to the levels of endogenous cortical NuMA and Dynein in metaphase? Also, in Figure 1B-F, the authors show that illuminating a tiny portion of the cortex is sufficient to recruit extended cortical crescents of NuMA. How do the authors explain this extended NuMA cortical distribution molecularly?

\- In Figure 4, the authors engineer RFP-Nano NuMA fragments and test their ability to recruit Dynein at the cortex and position the spindle. As a positive control they use NuMA-Δ-NLS explaining that it does not dimerize with endogenous NuMA. Can the authors explain why NLS removal would prevent dimerisation?

\- A major finding of the manuscript is the identification of cortical NuMA/Dynein clusters that are required for astral MT-pulling forces. A critical issue is to which extent the clustering might be affected by the protein engineering used to visualise and localise the proteins.

In the presented experiments, the levels of NuMA at the cortex seem to vary significantly depending on the construct (see Figure 4 and Figure 5). In addition, in the Figure 5---figure supplement 1 the authors report that the construct 1-1985 tends to aggregate at the cortex. Can the authors comment on the specificity of the dotted pattern they see -- i.e. whether the constructs are stable and soluble? One consideration that comes to my mind is that the 5A-2 and 5A-3 residue stretches of NuMA that are responsible for clustering correspond to hydrophobic residues, that might be engaged in intramolecular interactions maintaining the protein stability. Of note, for some reasons, the dotted pattern does not seem evident in Figure 1.

On the same line of thoughts, in Figure 6B and Figure 6---figure supplement 1C, the authors use GFP-NuMA-C-3A mutant that localizes at the cortex as it lacks the inhibitory cdk1 phosphorylation sites. In a wild-type background, this construct should be recruited at the membrane by LGN. Is the dotted structure of GFP-NuMA-C visible upon LGN cortical recruitment? In Figure 6---figure supplement 1C the authors show that the punctuated NuMA-3A pattern intercalates with the cortical actin pattern. This is an interesting observation, can the authors comment on this?

\- One of the issues connected to the idea of NuMA clusters relates to the molecular events underlying their formation under physiological conditions. The authors identify NuMA residues responsible for the clustering: do they think these residues mediate self-oligomerization of NuMA? In the experiments of Figure 7B and Figure 7---figure supplement 1F, in which endogenous NuMA is replaced with full-length NuMA either wild-type or 5A-3, the cortical clustering does not seem very evident.

\- In the Discussion, the authors propose that NuMA clustering works within a DDN network to promote end-on attachment of astral microtubules to the cortex. To my knowledge, no compelling evidence for end-on attachment in this process has been provided. This model, although possible, tends to reflect what known for the attachment of microtubules to kinetochore. Therefore, in the absence of specific evidence, it might be preferable to down-state the model.

Reviewer \#3:

1\) The idea that NuMA may activate dynein in addition to regulating its localization is an attractive hypothesis, which has been proposed by others but not carefully tested. Similarly, this work includes no direct data related to dynein activation. The authors show that the Spindly-like motif is required for dynein recruitment, but they do not decouple recruitment (localization) and activation. Thus, the use of language throughout the paper referring to dynein activation could be misleading; it should be softened and mostly confined to the Discussion. It should be made clear that the authors did not test whether NuMA activates dynein.

2\) In the experiments in Figures 4 and 5, why is NuMA 1-2115 ΔNLS used instead of the full-length protein? In the subsection "A Spindly-like motif in NuMA is required for cortical dynein recruitment, but not sufficient for spindle pulling", the authors state that the NLS is removed to prevent dimerization with endogenous protein, but do not state a source. Do they believe this to be true, and due to what published or unpublished data? Published work (e.g., Harborth et al., EMBO 1995) suggests that dimerization will still occur through NuMA\'s coiled-coils.

3\) Relatedly, dimerization with endogenous NuMA presumably occurs with NuMA truncations in Figures 4 and 5 that include some or all of the central coiled-coil. Could the authors comment on how this dimerization could affect their conclusions based on these data? As one example, could the inability of fragment \#12 reflect an inability to form a functional dimer with endogenous protein due to absence of big part of the central coiled-coil?

4\) In Figure 4C and 5B, the application of a z-test to \"yes/no\" data (not normally distributed) with low \"N\" is likely inappropriate. We suggest using the actual pole displacement distances (as a percentage of starting pole-to-cortex distance) for each condition, and then analyzing those data using an ANOVA (or, at least, a t-test between the control (\#1) and each condition). Consulting a statistician may be helpful.

5\) Relatedly, directly reporting the actual pole displacement distances for NuMA fragments \#1-14 (Figure 4-5) would be interesting and important for the reader to interpret the data. These data could be displayed as \"beeswarm\" plots like Figure 7C, for example, and they would help the reader better interpret the significance of your findings (for example, it would better display the degree of spindle displacement difference between NuMA fragment \#11 (3/8) and fragment \#14 (1/13)).

6\) In model Figure 7D (and related Figure 7---figure supplement 1), the main features of the cartoon should stay as close to what was shown in the paper as possible. If there is key speculation not supported by data, it should be made clear that it is speculation. In particular, whether LGN forms a ring does not seem to be based on data and drawing LGN and NuMA\'s C-terminus as more disorganized may avoid readers being biased towards a ring-like model (alternatively, if a ring-like model is supported by data, it should be made clear what data supports it).

10.7554/eLife.36559.027

Author response

> Essential revisions:
>
> Experimental:
>
> The reviewers ask for two pieces of experimental data. The first needs to be addressed if possible. The second would clearly add to the paper, but the reviewer leaves it up to you as to whether you want to include it -- if not then you should address the reviewers questions.
>
> 1\) Most of the experiments presented are conducted in an LGN silenced background, thus it seems that pulling forces do not require LGN nor Gαi. For the sake of completeness, it would be beneficial to show LGN levels at the end of the experiments, i.e. after 72 hours from siRNA treatment, and at the same time test the effect of removing Gαi.

We performed a Western blot to demonstrate the reduction of LGN protein level after siRNA treatment. This data is now included in Figure 1---figure supplement 1H. In addition, we conducted light-induced NuMA targeting in a Gαi (1+2+3) silenced background. The metaphase spindle was displaced toward the light-illuminated region in 71.4% of cells (n=7), similarly to in LGN-depleted cells. These data are now included in Figure 1---figure supplement 2E-F. Taken together, these results indicate that cortical pulling forces do not require LGN or Gαi in our optogenetic system.

> 2\) Dynein-dynactin recruitment requires a Spindly-like motif in NuMA\'s N-terminal region. This is an intriguing finding that suggests mechanistic similarities between functionally diverse dynein adaptors. However, the authors also show that NuMA\'s N-terminal region is not sufficient for cortical force generation. This raises the question of how good NuMA\'s N-terminal region really is at activating dynein. For comparison, it might be interesting to check whether cortical targeting of the N-terminal BICD2 region, which robustly activates dynein-dynactin motility in vitro and in vivo, is sufficient for force generation in this assay.

We have now cloned human N-terminal BICD2 region (1-400 aa) and generated cell line that conditionally expresses BICD2-N-RFP-Nano in the presence of Dox. Unexpectedly, light-induced targeting of the BICD2-N construct was not sufficient to recruit dynein (DHC-SNAP) to the mitotic cell cortex (n=10), although the BICD2-N construct was able to partially recruit dynein to the plasma membrane in interphase (n=5/8 cells) (Please see [Author response image 1](#respfig1){ref-type="fig"}). These results suggest that interaction between dynein and BICD2-N is during cell cycle, and thus BICD2-N targeting is not a feasible way to dissect dynein-based force generation during mitosis. Because of these reasons, we did not include these data in the revised manuscript.

![](elife-36559-resp-fig1){#respfig1}

Alternatively, to understand whether light-induced NuMA-dynein complexes require dynein activity for spindle displacement, we analyzed the effect of ciliobrevin D on force generation. This drug inhibits dynein-dependent microtubule gliding and ATPase activity, but not the association between ADP-bound dynein and microtubules in vitro (Firestone et al., 2012). In HCT116 cells, we found that ciliobrevin D treatment in interphase caused mitotic phenotypes including chromosome misalignment similar to dynein degradation (Natsume et al., 2016) under 0.5%, but not 10% FBS culture conditions (Figure 3---figure supplement 1B-D), consistent with previous reports (Firestone et al., 2012). We next added ciliobrevin D to metaphase-arrested cells. Although dynein activity is required to maintain spindle bipolarity, we found that spindle bipolarity was maintained for \~30 min following the treatment of ciliobrevin D, and was gradually disrupted during the subsequent 30-60 min (Figure 3---figure supplement 1E-G). Thus, we next sought to perform spindle pulling assay during the initial 60 min according to the Procedure depicted in Figure 3A. In control cells, light-induced targeting of NuMA displaced the spindle in 80% of cell (n=10, Figure 3B and D). In contrast, the spindle was not displaced in 75% of ciliobrevin D-treated cells (n=12, Figure 3C-D), whereas dynein was normally recruited to the cell cortex and the spindle structure was maintained during the assay. These results suggest that light-induced NuMA activates dynein and its activity is required for generating cortical pulling forces. These data are now included in Figure 3A-D, and Figure 3---figure supplement 1A-G.

We also performed the same assay using cells expressing NuMA's N-terminal fragment (1-705 aa; Figure 4B, C \#3) to test whether asymmetric spindle-pole enrichment of the NuMA N-terminal fragment (Figure 4F) depends on dynein activity. However, in 0.5% FBS culture condition, the N-terminal NuMA fragment displays large cytoplasmic aggregation, which accumulates around spindle poles during mitosis, and prevented us from analyzing asymmetric spindle-pole enrichment of this fragment after light-induced cortical targeting.

In total, our results indicate that NuMA not only recruits dynein-dynactin to the mitotic cell cortex but also activates dynein at the cell cortex to generate cortical pulling forces. Although it is still unclear how good NuMA's N-terminal region activates dynein, we believe that these new additions provide a strong evidence that dynein is activated following NuMA-mediated cortical recruitment to generate functional spindle-pulling forces.

> Manuscript revisions:
>
> The reviewers have also identified a number of points that need clarification in order to improve the manuscript. I attach the list of these below. Please address these points in your response to the reviewers and make changes to the manuscript where appropriate.
>
> Reviewer \#1:
>
> \- Robust spindle displacement is observed after addition of taxol (Figure 2). This is surprising given the end-on microtubule binding by NuMA clusters proposed by authors, which requires shortening of microtubules to pull the spindle towards the cortex. The authors should comment on how the taxol result is compatible with their model.

In taxol-treated cells, the velocity of the spindle movement was slower than that observed in control cells (Figure 2I), suggesting that depolymerization of astral microtubules may also contribute to force generation as described in the model. Of course, this reduced velocity may be due to other reasons such as cortical pushing by stabilized astral microtubules. Thus, we have added comments to the revised manuscript as described below.

"In these taxol-treated cells, the velocity of the spindle movement was slower than that observed in control cells (Figure 2F-I), suggesting that depolymerization of astral microtubules may also contribute to force generation, although the reduced velocity might be caused alternatively by cortical pushing by stabilized astral microtubules."

> \- The authors show that direct targeting of dynein to the cortex (which also results in dynactin recruitment) is not sufficient per se for the generation of cortical pulling forces and that cortical force generation requires the second microtubule binding domain of NuMA. These findings are in agreement with the results of Seldin, Muroyama, and Lechler (2016), who showed that the microtubule-binding activity of NuMA is required for mitotic spindle positioning in cultured mouse keratinocytes and the epidermis. This should be explicitly acknowledged by the authors.

We now cited this paper as follows:

"... direct binding of NuMA to astral microtubules may generate cooperative forces in parallel with dynein-dynactin recruitment as recently proposed by Seldin et al. (Seldin, Muroyama, and Lechler, 2016)."

In addition, we have added comments for why NuMA Δex24, which corresponds to the mouse NuMAΔex22 mutant used in Seldin et al. paper, is still be able to generate pulling forces in our assay as follows.

"Because the corresponding mouse NuMA Δex22 mutant shows spindle orientation defect in mouse keratinocytes and the epidermis (Seldin et al., 2016), this region may have specific roles in different cell types. Alternatively, weak defects in the NuMA Δex24 mutant may be suppressed by targeting increased levels of cortical NuMA Δex24 in this assay."

> \- The generation of cortical pulling forces requires the central coiled-coil region of NuMA. This contrasts with the observation that the same NuMA region is dispensable for spindle pole focusing, as shown by Hueschen et al. (2017). The context-dependent requirement for NuMA\'s central coiled-coil region is interesting and should be commented on.

We appreciate this comment. The following sentences are now included in Discussion:

"Interestingly, spindle pole focusing requires both NuMA's C-terminal minus-end binding and N-terminal dynein-dynactin binding modules, but not its central long coiled-coil (Hueschen et al., 2017). Whereas NuMA-dynein complexes generate active forces within cells, NuMA's multiple modules appear to be differently utilized depending on the context."

> \- The generation of cortical pulling forces requires clustering of NuMA at the cortex, which is mediated by a highly conserved patch in NuMA\'s C-terminal region. This is perhaps the most important conclusion of this study and suggests a mechanism similar to the one used by the kinetochore, where multiple microtubule-binding activities are concentrated for stable end-on attachment. The authors should clarify the following points: does NuMA clustering occur independently of astral microtubules?

The GFP-NuMA-C 3A fragment shows punctate signals in nocodazole-arrested cells (Figure 6B). In addition, NuMA forms oligomers in vitro (Harborth et al., 1999). Thus, we believe that NuMA is able to cluster independently of astral microtubules. We have now added (+Nocodazole) in Figure 6B. However, we cannot exclude the possibility that astral microtubules assist NuMA clustering in cells. We have now included the following sentence in the Discussion:

"Alternatively, astral microtubule binding of the DDN complex may also assist cluster formation on the cell cortex."

> In the model (Figure 7D), LGN clusters with NuMA -- but is there evidence for this?

We generated a NuMA-mACF and SNAP-LGN double knock-in HCT116 cell line, and visualized both NuMA and LGN. We found that LGN also displays punctate cortical signals as observed in Rpe1 cells (Figure S4b in Kiyomitsu and Cheeseman, 2012). We now included this data in Figure 7---figure supplement 1C.

> \- Figure 4C: the number of cells examined in the \'spindle displacement\' assay for NuMA fragments \#3 and \#6 is too low (2 and 3, respectively).

We have now repeated this experiment using the NuMA \#3 cell line, and increased the number of cells up to 7 in the spindle displacement assay. Together with the results of NuMA \#2 construct (n=14), these data indicate that NuMA's N-terminal fragment is not sufficient for spindle displacement. For the NuMA \#6 cell line, we have changed this to n.d. (not determined) in Figure 4C because of the low number of cells.

> Reviewer \#2:
>
> \- The light-induced system adopted in the article enables local recruitment of NuMA-RFP-Nano (or Dynein-RFP-Nano) to the cortex by hetero-dimerization of the fusion proteins with activated membrane-bound iLID. It is known that NuMA cortical levels are critical in determining the extent of spindle pulling forces. What are the levels of NuMA-RFP-Nano and Dynein-RFP-Nano recruited at the cortex upon light induction compared to the levels of endogenous cortical NuMA and Dynein in metaphase?

Although we have quantified the level of NuMA-RFP-Nano and DHC-SNAP in the previous Figure 1---figure supplement 1, we did not clearly describe these data. We now describe this data as follows.

"The level of light-induced cortical NuMA is about 3 times higher than that of endogenous NuMA in metaphase, but similar to that in anaphase (Figure 1---figure supplement 1I-J)."

The level of cortical Nano-mCherry-DHC is also quantified in Figure 3G. This Nano-mCherry- DHC level is higher than that of endogenous SNAP-DHC in Figure 1C, suggesting that failure of force generation by light-induced dynein targeting is not due to its lower level of cortical dynein.

> Also, in Figure 1B-F, the authors show that illuminating a tiny portion of the cortex is sufficient to recruit extended cortical crescents of NuMA. How do the authors explain this extended NuMA cortical distribution molecularly?

One reason for the illumination of a small region promoting crescent formation is the diffusion of NuMA-RFP-Nano/ Mem-BFP-iLID complex on the plasma membrane. These complexes can move about 5 μm within 60 sec when a diffusion constant (D = 0.1 μm^2^/sec) for a typical membrane bound protein is used for the calculation. In addition, this illumination may be affected by technical reasons related to the optics. In principle, the laser is focused and illuminated at the defined region on the focal plane with maximum power. However, the laser also penetrates its vertical region with wider breadth. Because mitotic cells have a round shape compared to interphase cells, such wider vertical illumination may stimulate its vertical region, and cause wider distribution of NuMA-RFP-Nano on the focal plane following diffusion. Other reasons such as light scattering by unknown cellular components may also cause a wider illumination. Nonetheless, endogenous NuMA and dynein normally extend along the cell cortex as shown in Figure 1B left. Thus, we believe that the extended NuMA cortical distribution is similar to its native localization and is appropriate to assess its ability for cortical force generation.

> \- In Figure 4, the authors engineer RFP-Nano NuMA fragments and test their ability to recruit Dynein at the cortex and position the spindle. As a positive control they use NuMA-Δ-NLS explaining that it does not dimerize with endogenous NuMA. Can the authors explain why NLS removal would prevent dimerisation?

We removed the NLS to spatially separate exogenously expressed NuMA constructs from endogenous NuMA, which dominantly localizes to the nucleus in interphase cells. In fact, based on our synchronized expression protocol as described in Figure 4---figure supplement 1B, exogenously expressed NuMA constructs localized to the cytoplasm before G2 release (at 68 hr), and separated from endogenous NuMA in the nucleus, suggesting that the large majority of exogenously expressed NuMA mutants form homo-dimers through its coiled-coil in the cytoplasm, but not with endogenous NuMA. The following sentences are now included:

"the NLS was deleted to reduce dimerization with endogenous NuMA by spatially separating exogenously expressed constructs from nuclear-localized endogenous NuMA before G2 release."

> \- A major finding of the manuscript is the identification of cortical NuMA/Dynein clusters that are required for astral MT-pulling forces. A critical issue is to which extent the clustering might be affected by the protein engineering used to visualise and localise the proteins.
>
> In the presented experiments, the levels of NuMA at the cortex seem to vary significantly depending on the construct (see Figure 4 and Figure 5). In addition, in the Figure 5---figure supplement 1 the authors report that the construct 1-1985 tends to aggregate at the cortex. Can the authors comment on the specificity of the dotted pattern they see -- i.e. whether the constructs are stable and soluble? One consideration that comes to my mind is that the 5A-2 and 5A-3 residue stretches of NuMA that are responsible for clustering correspond to hydrophobic residues, that might be engaged in intramolecular interactions maintaining the protein stability. Of note, for some reasons, the dotted pattern does not seem evident in Figure 1.

At present, we do not have data regarding the stability and solubility of each NuMA construct. To answer this question, future work will be necessary to express these constructs in vitro and analyze their structural and biochemical properties, which we believe is beyond the scope of this study. Regarding the dotted pattern, smaller constructs such as NuMA-C show more visible punctate signals. Although we repeatedly observe punctate signals for full length NuMA, it is difficult to recognize clear dots as for NuMA-C. This may indicate dynamic assembly and/or reorganization of NuMA clusters in addition to their lateral diffusion on the cell cortex. Alternatively, NuMA-C may form additional oligomeric structure. We have now included the following sentence in the Results section.

"... we found that NuMA constructs containing its C-terminal region displayed punctate cortical signals, which tend to be more evident in smaller constructs (e.g. Figure 5H-I)".

> On the same line of thoughts, in Figure 6B and Figure 6---figure supplement 1C, the authors use GFP-NuMA-C-3A mutant that localizes at the cortex as it lacks the inhibitory cdk1 phosphorylation sites. In a wild-type background, this construct should be recruited at the membrane by LGN. Is the dotted structure of GFP-NuMA-C visible upon LGN cortical recruitment?

Although NuMA-C contains the LGN binding domain, GFP-NuMA-C WT is hardly detectable at the metaphase cell cortex (Please see Figure 1F and 1G in Kiyomitsu and Cheeseman, 2013), suggesting that NuMA-C is not sufficient to interact with LGN. In fact, LGN was not detected as a GFP-NuMA-C 3A binding proteins in our previous mass spectrometry analysis (Kiyomitsu and Cheeseman, 2013), and is dispensable for punctate signal formation of GFP-NuMA-C-3A (Figure 2C in Kiyomitsu and Cheeseman, 2013).

> In Figure 6---figure supplement 1C the authors show that the punctuated NuMA-3A pattern intercalates with the cortical actin pattern. This is an interesting observation, can the authors comment on this?

We appreciate this comment. We have now added following comments to the text:

"Interestingly, the punctate NuMA-C 3A patterns intercalated with cortical actin localization, and still existed following actin disruption (Figure 6---figure supplement 1C). These results suggest that the NuMA C-terminal fragment self-assembles on the membrane independently of its cortical binding partners and actin cytoskeleton."

> \- One of the issues connected to the idea of NuMA clusters relates to the molecular events underlying their formation under physiological conditions. The authors identify NuMA residues responsible for the clustering: do they think these residues mediate self-oligomerization of NuMA? In the experiments of Figure 7B and Figure 7---figure supplement 1F, in which endogenous NuMA is replaced with full-length NuMA either wild-type or 5A-3, the cortical clustering does not seem very evident.

Under physiological condition, cortical NuMA signals at metaphase are weak, and thus it is difficult to see punctate signals, especially when NuMA was visualized with the less intense mCherry. However, when we visualize endogenous NuMA with the brighter mClover, we repeatedly observed clear punctate NuMA signals as shown in Figure 7---figure supplement 1B-C. Because we think these residues mediate self-oligomerization of NuMA, for future work will conduct in vitro reconstitution of NuMA and selected mutants to visualize their structure as described by Harborth et al., 1999. However, this work is beyond the current paper.

> \- In the Discussion, the authors propose that NuMA clustering works within a DDN network to promote end-on attachment of astral microtubules to the cortex. To my knowledge, no compelling evidence for end-on attachment in this process has been provided. This model, although possible, tends to reflect what known for the attachment of microtubules to kinetochore. Therefore, in the absence of specific evidence, it might be preferable to down-state the model.

By analyzing the dynamics of EB3 and tubulin, Kozlowski et al., demonstrated that astral microtubule ends tend to interact with the cell cortex through an end-on configuration in *C. elegans* embryos. Similar results were reported in metaphase human cells by Samora et al. and Kwon et al. Thus, we propose that astral microtubule tips are captured by cortical force-generating machinery as an end-on configuration. However, as suggested by the reviewer, it is still unclear how the DDN clusters interact with astral microtubule plus-ends compared to the more advanced understanding of plus end interactions at kinetochores. Thus, according to the suggestion, we have reworded our model to provide caution as indicated below, and have highlighted that the ring-like structure for a NuMA cluster is an imaginary structure based on Harborth et al., in Figure 7---figure supplement 1G.

"... and astral microtubules tend to interact with the cell cortex through an end-on configuration in pre-anaphase cells (Kozlowski, Srayko, and Nedelec, 2007; Kwon, Bagonis, Danuser, and Pellman, 2015; Samora et al., 2011), it is tempting to speculate that the DDN cluster encircles or partially wraps the plus tip of a single astral microtubule ..."

"The ring-like structure for a NuMA cluster is an imaginary structure based on Harborth et al., (Harborth et al., 1999)."

> Reviewer \#3:
>
> 1\) The idea that NuMA may activate dynein in addition to regulating its localization is an attractive hypothesis, which has been proposed by others but not carefully tested. Similarly, this work includes no direct data related to dynein activation. The authors show that the Spindly-like motif is required for dynein recruitment, but they do not decouple recruitment (localization) and activation. Thus, the use of language throughout the paper referring to dynein activation could be misleading; it should be softened and mostly confined to the Discussion. It should be made clear that the authors did not test whether NuMA activates dynein.

We appreciate this comment. To answer this question, we have now tested the effect of ciliobrevin D, an inhibitor of dynein activity, on spindle displacement caused by light-induced NuMA targeting. We carefully optimized the experimental conditions and found that ciliobrevin D treatment disrupts spindle displacement following cortical NuMA targeting. This result suggests that NuMA activates dynein. This data is now included in Figure 3A-D and Figure 3---figure supplement 1A-G.

> 2\) In the experiments in Figures 4 and 5, why is NuMA 1-2115 ΔNLS used instead of the full-length protein? In the subsection "A Spindly-like motif in NuMA is required for cortical dynein recruitment, but not sufficient for spindle pulling", the authors state that the NLS is removed to prevent dimerization with endogenous protein, but do not state a source. Do they believe this to be true, and due to what published or unpublished data? Published work (e.g., Harborth et al., EMBO 1995) suggests that dimerization will still occur through NuMA\'s coiled-coils.

As also described above in response to reviewer \#2:

We removed the NLS to spatially separate exogenously expressed NuMA constructs from endogenous NuMA, which dominantly localizes in the nucleus of interphase cells. In fact, based on our synchronized expression protocol as described in Figure 4---figure supplement 1B, exogenously expressed NuMA constructs localized in cytoplasm before G2 release (at 68 hr), and separated from endogenous NuMA in the nucleus, suggesting that large majority of exogenously expressed NuMA mutants form homo-dimers through coiled-coil in the cytoplasm, but not with endogenous NuMA.

"... the NLS was deleted to eliminate dimerization with endogenous NuMA by spatially separating the exogenously expressed constructs from nuclear-localized endogenous NuMA before G2 release."

In addition, we have performed these experiments with NLS containing full-length protein. In this case, exogenously expressed NuMA-RFP-Nano accumulated in the nucleus before G2, but was unable to displace the spindle efficiently (11.1%, n=9) during mitosis. We think that exogenously expressed full length NuMA forms heterodimers with endogenous NuMA lacking RFP-Nano, which leads to an inability of force generation due to weaker cortical anchorage. We have now added following comments to the text:

"In contrast, exogenously expressed NLS containing NuMA-RFP-Nano (1-2115) accumulated in the nucleus before G2, but was unable to displace the spindle efficiently (11.1%, n=9), likely due to weak cortical anchorage by hetero-dimerization with endogenous NuMA lacking RFP-Nano."

> 3\) Relatedly, dimerization with endogenous NuMA presumably occurs with NuMA truncations in Figures 4 and 5 that include some or all of the central coiled-coil. Could the authors comment on how this dimerization could affect their conclusions based on these data? As one example, could the inability of fragment \#12 reflect an inability to form a functional dimer with endogenous protein due to absence of big part of the central coiled-coil?

All constructs except for NuMA-C \#13 localized to the cytoplasm prior to G2 release in our synchronized protocol. Thus, we believe that these exogenously expressed constructs are spatially separated from endogenous NuMA before entering mitosis, and thus the majority of exogenously-expressed NuMA would not form heterodimers with endogenous NuMA during mitosis. NuMA-C \#13 localized to the nucleus before G2 release, but this construct lacks the coiled-coil region required for dimerization, and thus we think that this construct does not dimerize with endogenous NuMA.

> 4\) In Figure 4C and 5B, the application of a z-test to \"yes/no\" data (not normally distributed) with low \"N\" is likely inappropriate. We suggest using the actual pole displacement distances (as a percentage of starting pole-to-cortex distance) for each condition, and then analyzing those data using an ANOVA (or, at least, a t-test between the control (\#1) and each condition). Consulting a statistician may be helpful.

According to this suggestion, we have now plotted the actual spindle displacement distance as a percentage of starting pole-to-cortex distance for each condition in Figure 4---figure supplement 1J. Because these samples do not show a clear Gaussian distribution, we performed a Mann-Whitney test, which can be applicable for such samples with low N (N\>4). Although \#2 and \#11 are not significantly different, other samples show statistical difference (p\<0.05) compared to control (\#1). This data is now included in Figure 4---figure supplement 1J and mentioned in the figure legend.

> 5\) Relatedly, directly reporting the actual pole displacement distances for NuMA fragments \#1-14 (Figure 4-5) would be interesting and important for the reader to interpret the data. These data could be displayed as \"beeswarm\" plots like Figure 7C, for example, and they would help the reader better interpret the significance of your findings (for example, it would better display the degree of spindle displacement difference between NuMA fragment \#11 (3/8) and fragment \#14 (1/13)).

According to this suggestion, the data is now included in Figure 4---figure supplement 1J.

> 6\) In model Figure 7D (and related Figure 7---figure supplement 1), the main features of the cartoon should stay as close to what was shown in the paper as possible. If there is key speculation not supported by data, it should be made clear that it is speculation. In particular, whether LGN forms a ring does not seem to be based on data and drawing LGN and NuMA\'s C-terminus as more disorganized may avoid readers being biased towards a ring-like model (alternatively, if a ring-like model is supported by data, it should be made clear what data supports it).

We have now commented that the ring-like structure is imaginary based on Harborth et al., 1999. In addition, we have included a non-ring structure model in Figure 7---figure supplement 1G. Because we found that LGN also displays punctate signals like NuMA, we drew LGN together with NuMA. This data is now included in Figure 7---figure supplement 1C.

"The ring-like structure for a NuMA cluster is an imaginary structure based on Harborth et al., (Harborth et al., 1999)."
